<p>Four groups of mice (4 per group) were primed with PBS (mock), H1N1 16E6E7 virus, H1N1 16E6E7m virus, parental H1N1 delNS1 virus, or 16L1/L2-E7 VLPs, and boosted 10 days later with PBS, corresponding H3N2 serotypes, or VLPs. Mice were sacrificed <b>A</b> 10 days or <b>B</b> 30 days after boosting, splenocytes were isolated and stimulated in triplicates for 24 h with antigen peptides, SEA or medium alone. For mock and influenza A virus-vaccinated animals, NP<sub>311-325</sub> peptide, for mice immunized with 16L1/L2-E7 VLP, 16L1<sub>165-173</sub> peptide were used as positive controls. Shown are numbers of IFN-γ spots, counted under a light microscope, and plotted as mean ± SD of triplicate wells. One representative experiment of two is s...
<p>Groups of mice (n = 3) were inoculated with IDLV-NP 2 times i.n. or i.m., 4 weeks apart. Mice (n ...
<p>The anti-HPV16 L1 IgG and anti-HPV16 neutralizing antibody titers of the PBS-, hHPV16 VLP- and cH...
Persistent infection with high-risk human papillomavirus (HPV) types, most often HPV16 and HPV18, ca...
<p><b>A</b> Schematic illustration of the experimental set up. <b>B</b> Groups (n = 8) of C57BL/6 fe...
<p>Groups of C57BL/6 mice (n = 3) were s.c. immunized twice (day 0 and 10) with 2μg of either wt HPV...
<p><b>A</b> Schematic illustration of the experimental set up <b>B</b> Five groups of female C57BL/6...
<p>C57BL/6 mice were immunized intranasally with 1, 3, or 10 μg of HA-equivalent of BPL-inactivated ...
<p>The primary IAV infection was conducted as described in the legends to <a href="http://www.plospa...
The transforming protein E7 of human papilloma virus type 16 can stimulate cytotoxic T lymphocytes (...
<p>Balb/c mice were immunized (intramuscularly) twice at two weeks intervals with 5 µg of 16L2(17–31...
<p>(A) groups of 3 (young) and 12 (old) month old mice were primed with 10<sup>5</sup> PFU of MCMV, ...
Persistent infection with high-risk human papillomavirus (HPV) types, most often HPV16 and HPV18, ca...
<p>Animals received one of three variations of the HPV16 particle: L1 only, L1/L2 empty particles or...
<p>Six—eight weeks old female BALB/c mice (n = 10 per group) were immunized with 10<sup>10</sup> f88...
<p>C57BL/6 mice (5 per group) vaccinated twice intramuscularly with AAVLP(HPV16/31L2) particles eith...
<p>Groups of mice (n = 3) were inoculated with IDLV-NP 2 times i.n. or i.m., 4 weeks apart. Mice (n ...
<p>The anti-HPV16 L1 IgG and anti-HPV16 neutralizing antibody titers of the PBS-, hHPV16 VLP- and cH...
Persistent infection with high-risk human papillomavirus (HPV) types, most often HPV16 and HPV18, ca...
<p><b>A</b> Schematic illustration of the experimental set up. <b>B</b> Groups (n = 8) of C57BL/6 fe...
<p>Groups of C57BL/6 mice (n = 3) were s.c. immunized twice (day 0 and 10) with 2μg of either wt HPV...
<p><b>A</b> Schematic illustration of the experimental set up <b>B</b> Five groups of female C57BL/6...
<p>C57BL/6 mice were immunized intranasally with 1, 3, or 10 μg of HA-equivalent of BPL-inactivated ...
<p>The primary IAV infection was conducted as described in the legends to <a href="http://www.plospa...
The transforming protein E7 of human papilloma virus type 16 can stimulate cytotoxic T lymphocytes (...
<p>Balb/c mice were immunized (intramuscularly) twice at two weeks intervals with 5 µg of 16L2(17–31...
<p>(A) groups of 3 (young) and 12 (old) month old mice were primed with 10<sup>5</sup> PFU of MCMV, ...
Persistent infection with high-risk human papillomavirus (HPV) types, most often HPV16 and HPV18, ca...
<p>Animals received one of three variations of the HPV16 particle: L1 only, L1/L2 empty particles or...
<p>Six—eight weeks old female BALB/c mice (n = 10 per group) were immunized with 10<sup>10</sup> f88...
<p>C57BL/6 mice (5 per group) vaccinated twice intramuscularly with AAVLP(HPV16/31L2) particles eith...
<p>Groups of mice (n = 3) were inoculated with IDLV-NP 2 times i.n. or i.m., 4 weeks apart. Mice (n ...
<p>The anti-HPV16 L1 IgG and anti-HPV16 neutralizing antibody titers of the PBS-, hHPV16 VLP- and cH...
Persistent infection with high-risk human papillomavirus (HPV) types, most often HPV16 and HPV18, ca...